The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Population-based studies have reported mixed findings on the potential association between GLP-1RA use and aspiration pneumonia (39–44).”
From The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A retrospective cohort study using the TriNetX dataset revealed a significant correlation between GLP-1 RAs use and elevated aspiration pneumonia risk in patients undergoing gastrointestinal endoscopy, particularly among those receiving propofol sedation [20].”
From Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Conversely, Yeo et al. [48], in a propensity score–matched cohort study including patients using a broad range of GLP-1 RAs, reported that GLP-1 RA therapy may be associated with an increased risk of aspiration pneumonia during endoscopic procedures.”
From Delayed gastric emptying induced by glucagon-like peptide-1 receptor agonists and its implications for perioperative risk during anesthesia (2026) · cites this paper as [48]
In the citing paper
“In people using GLP-1 RAs long-term,48 there is less certainty in regard to the risk of pulmonary aspiration,49 particularly because the effect of tachyphylaxis on gastric emptying is unclear.”
From Evaluation of safety of preoperative GLP-1 receptor agonists in patients undergoing elective surgery: a systematic review, meta-analysis and meta-regression (2025) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hashash, J. G., Thompson, C. C., & Wang, A. Y. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.11.002 · Cited by 140
Ushakumari, D. S., & Sladen, R. N. (2024) · Anesthesiology · doi:10.1097/aln.0000000000004776 · Cited by 139
van Zuylen, M. L., Siegelaar, S. E., Plummer, M. P., Deane, A. M., Hermanides, J., & Hulst, A. H. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.01.001 · Cited by 132
Rézaiguia-Delclaux, S., Streich, B., Bouleau, D., Delchier, J. C., Dhonneur, G., Meignan, M. A., & Duvaldestin, P. (2001) · British Journal of Anaesthesia · doi:10.1093/bja/87.2.204 · Cited by 15
Parker, J. D. (2020) · JA Clinical Reports · doi:10.1186/s40981-020-00360-5 · Cited by 12
Research works printed but not linked: 1
- von Elm, 2008, 49, 688
Cited by
Sorted by citations
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383
Mapping the effectiveness and risks of GLP-1 receptor agonists
Xie, Y., Choi, T., & Al-Aly, Z. (2025) · Nature Medicine · doi:10.1038/s41591-024-03412-w · Cited by 300
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide
Jalleh, R. J., Plummer, M. P., Marathe, C. S., Umapathysivam, M. M., Quast, D. R., Rayner, C. K., Jones, K. L., Wu, T., Horowitz, M., & Nauck, M. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae719 · Cited by 157
El‐Boghdadly, K., Dhesi, J., Fabb, P., Levy, N., Lobo, D. N., McKechnie, A., Mustafa, O., Newland‐Jones, P., Patel, A., Pournaras, D. J., et al. (2025) · Anaesthesia · doi:10.1111/anae.16541 · Cited by 147
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
Jalleh, R. J., Rayner, C. K., Hausken, T., Jones, K. L., Camilleri, M., & Horowitz, M. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00188-2 · Cited by 144
Metadata
- Authors
- Yeo, Y. H., Gaddam, S., Ng, W. H., Huang, P.-C., Mohamed, G., Samaan, J., Yi-Jin Hsieh, T., Lee, G. Y., Watson, R., Mathur, R., Ma, K. S.-K., & Rezaie, A.
- Affiliations
- Cedars-Sinai Medical Center (US)
- University of Bristol (GB)
- Harvard University (US)
- Corresponding author
- Rezaie, Ali
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 167
- Issue
- 2
- Pages
- 402-404.e3
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W4393237412
- Cited by
- 128
- References
- 5
- Citations by year
- 2026: 38 · 2025: 57 · 2024: 33
- FWCI
- 37.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brigham and Women's Hospital
- Cedars-Sinai Medical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Airway Management and Intubation Techniques
- Keywords
- aspiration pneumonia, GLP-1 receptor agonists, endoscopy, drug safety, adverse drug reactions, gastrointestinal endoscopy
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Aged, Female, Humans, Hypoglycemic Agents, Male, Middle Aged, Pneumonia, Aspiration, Retrospective Studies, Risk Factors, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
